Balmain Beauty Introduces Destin de Balmain: A New Prestige Fragrance

PARIS--(BUSINESS WIRE)--Balmain Beauty unveils Destin de Balmain, its debut prestige fragrance. The new feminine fragrance is a bold, floral fruity eau de parfum that captures the unstoppable energy of the Balmain woman: independent, youthful, and unapologetic. THE STORY: LIVE YOUR DESTINY Destin de Balmain is destiny you hold in your hands, a journey of optimism and infinite possibilities. The refillable fragrance unites those who express themselves without rules or expectations. Inspired by t.

Business Wire • Feb 20, 2026

Beauty & Cosmetics Growth Story: Radiant Stocks You Should Watch

As the beauty and cosmetics industry balances resilience with innovation, IPAR, EL and ELF stand out for their brand strength and strategic execution.

Zacks Investment Research • Feb 20, 2026

Estée Lauder: The Storm Is Finally Over, But There Are Risks Involved

After a stellar performance in 2025, Estée Lauder's stock does not appear to be overvalued. A choppy business recovery is to be expected, but this should not dissuade long-term investors. The stock's high market risk should be taken into account, as the equity market poses a threat for high-beta stocks.

Seeking Alpha • Feb 18, 2026

Estee Lauder Posts a Higher Gross Margin Despite Tariff Pressures

EL expands the second-quarter fiscal 2026 gross margin by 40 basis points to 76.5% as PRGP savings and tighter inventory help offset tariff pressure.

Zacks Investment Research • Feb 17, 2026

Halper Sadeh LLC Encourages the Estee Lauder Companies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

GlobeNewsWire • Feb 12, 2026

Estée Lauder tested products sold on Walmart's site. What it found led to a lawsuit

Estée Lauder has accused Walmart of selling counterfeit beauty goods on its website in a lawsuit filed in California federal court earlier this week that namechecks celebrities including Taylor Swift and Beyoncé.

Fast Company • Feb 12, 2026

Wall Street Breakfast Podcast: Amazon Adds BETA To Cart

Amazon (AMZN) acquires a 5.3% stake in BETA Technologies, sharply boosting BETA's premarket share price. Moderna (MRNA) faces an FDA refusal-to-file for its mRNA-1010 influenza vaccine, citing inadequate trial controls but no safety or efficacy issues.

Seeking Alpha • Feb 11, 2026

Estee Lauder sues Walmart alleging 'despicable' sale of counterfeit beauty products

Estee Lauder sued Walmart over allegations it had counterfeit La Mer, Le Labo, Clinique, Aveda and Tom Ford beauty products listed on its online marketplace. While the products were sold by third-party sellers, Estee Lauder alleged Walmart played an active role facilitating those sales to shoppers, calling its conduct "despicable.

CNBC • Feb 10, 2026

5 Consumer Staples Giants to Buy Amid the Sector's Strong Momentum

Consumer staples are surging in 2026 as investors rotate to value, lifting XLP 13.2% YTD and spotlighting EL, HSY, KMB, MNST and NYT with renewed momentum.

Zacks Investment Research • Feb 10, 2026

These Analysts Revise Their Forecasts On Estee Lauder After Q2 Earnings

Estee Lauder Companies, Inc. (NYSE: EL) reported stronger-than-expected quarterly results on Thursday, driven by broad-based demand across regions and categories across its prestige beauty portfolio.

Benzinga • Feb 6, 2026